Perspective Therapeutics Completes Asset Acquisition

Ticker: CATX · Form: 8-K · Filed: Sep 20, 2024 · CIK: 728387

Sentiment: neutral

Topics: acquisition, definitive-agreement, exhibits

TL;DR

Perspective Therapeutics just bought some assets, filing shows.

AI Summary

Perspective Therapeutics, Inc. announced on September 18, 2024, the completion of its acquisition of certain assets. The company also entered into a material definitive agreement related to this transaction. Financial statements and exhibits pertaining to this event are included in the filing.

Why It Matters

This filing indicates a significant corporate action, potentially impacting the company's future operations and financial structure.

Risk Assessment

Risk Level: medium — Acquisitions carry inherent risks related to integration, valuation, and market reception.

Key Players & Entities

FAQ

What specific assets were acquired by Perspective Therapeutics, Inc.?

The filing indicates the completion of an acquisition of certain assets but does not specify the exact nature or details of these assets.

What is the nature of the material definitive agreement entered into by the company?

The filing states that a material definitive agreement was entered into, but the specific terms and purpose of this agreement are not detailed in the provided text.

When did the acquisition of assets by Perspective Therapeutics, Inc. officially take place?

The earliest event reported, which includes the completion of the acquisition, is dated September 18, 2024.

What were the previous names of Perspective Therapeutics, Inc.?

Perspective Therapeutics, Inc. was formerly known as Isoray, Inc. (and IsoRay, Inc.) and prior to that, CENTURY PARK PICTURES CORP.

What is the primary business of Perspective Therapeutics, Inc. according to its SIC code?

Perspective Therapeutics, Inc. is classified under Standard Industrial Classification code 3841, which pertains to Surgical & Medical Instruments & Apparatus.

Filing Stats: 1,028 words · 4 min read · ~3 pages · Grade level 13.5 · Accepted 2024-09-20 16:10:06

Key Financial Figures

Filing Documents

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. On September 18, 2024, Perspective Therapeutics, Inc. (the "Company") entered into a Master Equipment and Services Agreement (the "Agreement") and statements of work (the "Statements of Work") thereunder with Comecer SpA ("Comecer"), pursuant to which the Company agreed to purchase from Comecer manufacturing equipment for the production of the Company's radiopharmaceutical products including, but not limited to, isotope processing hot cells and production suites and related equipment (collectively, the "Deliverables") and services for installation and validation of the Deliverables at several of the Company's production facilities in the United States. The aggregate consideration for such equipment and services pursuant to the Agreement and the Statements of Work is approximately 49 million payable in cash, excluding certain incidental costs such as taxes, customs and duties, local transport, insurance and rigging. The Company may also elect to purchase certain additional equipment and services pursuant to the Statements of the Work. The Agreement provides for the payment of certain amounts in installments over the course of the production, installation and validation of the Deliverables. The Agreement contains representations and warranties of the parties that are customary for a transaction of this nature. In the event that Comecer terminates the Agreement and/or a Statement of Work due to the Company's insolvency, bankruptcy or uncured material breach, (i) Comecer shall have the right to take possession of all Deliverables and related materials and components (except such Deliverables, materials and components which have already been delivered to and paid for in full by the Company), (ii) Comecer will be under no obligation to finish the Deliverables or provide any warranty or any further work, support or information to the Company in relation to the Deliverables or otherwise, and (iii) the Company shall b

01 Completion of Acquisition or Disposition of Assets

Item 2.01 Completion of Acquisition or Disposition of Assets. The information disclosed under Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.01 in its entirety.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1+# Master Equipment and Services Agreement, dated as of September 18, 2024, by and between Perspective Therapeutics, Inc. and Comecer SpA. 10.2+# Form of Statement of Work Pursuant to Master Equipment and Services Agreement. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). + Certain portions of this exhibit (indicated by asterisks) have been omitted pursuant to Instruction 6 to Item 1.01 of Form 8-K. # Certain schedules or similar attachments to this exhibit have been omitted pursuant to Instruction 4 to Item 1.01 of Form 8-K. The Company will furnish supplementally a copy of any omitted schedule or exhibit to the Securities and Exchange Commission upon request. The Company may request confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended, for any schedules or exhibits so furnished .

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PERSPECTIVE THERAPEUTICS, INC. Date: September 20, 2024 By: /s/ Johan (Thijs) Spoor Johan (Thijs) Spoor Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing